Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Public ClinicalTrials.gov record NCT03850782. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.
Study identification
- NCT ID
- NCT03850782
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 515 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2019 (Actual)
- Primary completion
- Aug 8, 2025 (Actual)
- Completion
- Aug 8, 2025 (Actual)
- Last update posted
- Aug 19, 2025
2019 – 2025
United States locations
- U.S. sites
- 38
- U.S. states
- 20
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Horizon Eye Specialists & Lasik Centers /ID# 235240 | Sun City | Arizona | 85351 | — |
| Atlantis Eye Care /ID# 235530 | Huntington Beach | California | 92647 | — |
| Lakeside Vision Center /ID# 234970 | Irvine | California | 92604 | — |
| Global Research Foundation /ID# 237350 | Los Angeles | California | 90041-1718 | — |
| The Eye Research Foundation /ID# 234521 | Newport Beach | California | 92663-3637 | — |
| Byers Eye Institute Stanford /ID# 235544 | Palo Alto | California | 94303 | — |
| Foothill Eye Institute /ID# 235640 | Pasadena | California | 91107 | — |
| Connecticut Eye Consultants P.C. /ID# 234981 | Danbury | Connecticut | 06810 | — |
| Advanced Research, LLC /ID# 236045 | Deerfield Beach | Florida | 33064-1342 | — |
| Segal Drug Trials, Inc /ID# 235784 | Delray Beach | Florida | 33484 | — |
| International Research Center /ID# 238050 | Tampa | Florida | 33603 | — |
| Thomas Eye Group PC /ID# 235737 | Sandy Springs | Georgia | 30328 | — |
| Indiana University - Glick Eye Institute /ID# 235886 | Indianapolis | Indiana | 46202 | — |
| Retina Partners Midwest, PC /ID# 237876 | Indianapolis | Indiana | 46290 | — |
| Tulane University School of Medicine /ID# 237632 | New Orleans | Louisiana | 70112 | — |
| Ophthalmic Consultants of Boston /ID# 236534 | Boston | Massachusetts | 02129 | — |
| Clinical Eye Research of Boston LLC /ID# 234966 | Winchester | Massachusetts | 01890 | — |
| University of Michigan, Kellogg Eye Center /ID# 236496 | Ann Arbor | Michigan | 48105 | — |
| Fraser Eye Center /ID# 235790 | Fraser | Michigan | 48026 | — |
| Silverstein Eye Centers /ID# 237881 | Kansas City | Missouri | 64034 | — |
| Moyes Eye Centers /ID# 234989 | Kansas City | Missouri | 64154 | — |
| Alterman Modi & Wolter /ID# 235248 | Poughkeepsie | New York | 12603-2455 | — |
| The Ohio State University /ID# 236790 | Columbus | Ohio | 43210-1257 | — |
| AMA Eyes Research Institute /ID# 235542 | Marysville | Ohio | 43040 | — |
| Dean McGee Eye Institute /ID# 236823 | Oklahoma City | Oklahoma | 73104 | — |
| Oklahoma Eye Surgeons /ID# 235849 | Oklahoma City | Oklahoma | 73112 | — |
| Drs Fine Hoffman & Sims LLC /ID# 235918 | Eugene | Oregon | 97401 | — |
| Ophthalmic Partners, PC /ID# 235741 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Scott and Christie and Associates /ID# 234593 | Cranberry Township | Pennsylvania | 16066 | — |
| Black Hills Regional Eye Institute /ID# 235075 | Rapid City | South Dakota | 57701 | — |
| Vance Thompson Vision /ID# 235072 | Sioux Falls | South Dakota | 57108 | — |
| Eye Specialty Group /ID# 235721 | Memphis | Tennessee | 38120 | — |
| Vanderbilt University Medical Center /ID# 237177 | Nashville | Tennessee | 37232-0011 | — |
| Advancing Vision Research /ID# 236681 | Smyrna | Tennessee | 37167 | — |
| ATX Clinical Trials Inc. dba Keystone Research /ID# 235868 | Austin | Texas | 78731 | — |
| Medical Center Ophthalmology Associates - Keystone Research /ID# 235787 | San Antonio | Texas | 78240 | — |
| Southern Utah Medical Research /ID# 235602 | St. George | Utah | 84790 | — |
| Piedmont Eye Center /ID# 234534 | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03850782, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2025 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03850782 live on ClinicalTrials.gov.